Hope your right because they've achieved FA in my book with...

First 43 Last

Share
Profile

Follow
Jasper22

2,269 Posts.

506

04/07/24

12:32

Post #: 74605656
Share

Originally posted by Stockman: ↑

Hi Rebekah,
I was around back then (approximately 2014) when the share price spiked to $1.32 in waiting on the results of the study. Yes you are 100% right, the study ended up being a failure due to the flawed design of the study itself. The results of the study drew inconclusive at the time. After a full post mortem, PBT Management recognised where they fell short and set about to change things moving forward. Fast forward 10 years and now we not only have an "open study" in progress but also a "double blinded placebo study". The two biggest differences with each study is 1, the open label study is for long term MSA sufferers and the double blind placebo study is for new MSA Sufferers. The other difference is with the Open Label Study, Scientists can openly talk with the Patients and make adjustments throughout the Study based on each patients progress.
As Outlander2 pointed out a couple of days ago, we may see a difference in results from each study as the iron build up in a long term sufferers will be much greater and take a lot longer to rectify.
Either way, to answer the quote from 5 Cents, I still believe we are on the right track here. I believe we will definitely be successful and I am confident Dr Stamler has already engaged in conversation with potential partnering suitors. Dr Stamler is a sharp guy and a good operator. He has previous experience in taking orphan drugs to market. He certainly knows what it takes and I have all the confidence in the world he will get us over the finish line. One thing to take note of here is, we have so much to look forward to over the next six months leading up to the results of the double blind placebo study next January. Next weeks results aren't the bee all and end all of what ATH is doing, albeit important, we have other fish to fry over the coming 6 months. Giving Dr Stamler 120,000,000 Options is a massive sign we are certainly on the right track and we are going to be successful in due course. Dr Stamler would be looking for the exit doors rather than a big bag full of options if the trials weren't shaping up to be fruitful. Take a moment to let that resonate. This man is on a mission and he knows exactly what he is doing. Personally, I am really excited about the next 6 months and think Alterity may surprise us all.

Stockman

Expand

Hope your right because they've achieved FA in my book with the SP falling like it has

ATH Price at posting: 0.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

OPL

Opyl forms JV with UK and US consortium to bring products to the world

There are more pages in this discussion • 37 more messages in this thread...

First 43 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $21.28M

Open	High	Low	Value	Volume
0.4¢	0.5¢	0.4¢	$71.15K	17.43M

Buyers (Bids)

No.	Vol.	Price($)
101	87272775	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	24185511	15

View Market Depth

No.	Vol.	Price($)
101	87272775	0.004
62	57717766	0.003
15	31645515	0.002
17	108320103	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	24185511	15
0.006	22637365	20
0.007	26724705	23
0.008	29046938	31
0.009	17668789	11

Last trade - 16.10pm 24/07/2024 (20 minute delay)

ATH (ASX) Chart

Hope your right because they've achieved FA in my book with...

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Opyl forms JV with UK and US consortium to bring products to the world

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hope your right because they&apos;ve achieved FA in my book with...

Top Stories

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Opyl forms JV with UK and US consortium to bring products to the world

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hope your right because they've achieved FA in my book with...